Ultragenyx Pharmaceutical Inc. buy Jefferies Financial Group Inc.
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€53.50
Performance (%)
18.18%
Price
13.04.26
€19.61
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ currently has a performance of 18.18%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 1.606% | 1.606% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Jefferies Financial Group Inc. from $114.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat